These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10602189)

  • 21. The chemistry of the everninomicin antibiotics. II. The structure of everninocin and its identification with curacin.
    Reimann H; Jaret RS; Sarre OZ
    J Antibiot (Tokyo); 1969 Mar; 22(3):131-2. PubMed ID: 5789902
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential pulse polarographic analysis of everninomicin complex in fermentation broth.
    Kabasakalian P; Kalliney S; Westcott A
    J Pharm Sci; 1974 Apr; 63(4):641-2. PubMed ID: 4828727
    [No Abstract]   [Full Text] [Related]  

  • 23. MICROMONOSPORA CARBONACEA SP. N., AN EVERNINOMICIN-PRODUCING ORGANISM.
    LUEDEMANN GM; BRODSKY B
    Antimicrob Agents Chemother (Bethesda); 1964; 10():47-52. PubMed ID: 14287980
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin family.
    Foster DR; Rybak MJ
    Pharmacotherapy; 1999 Oct; 19(10):1111-7. PubMed ID: 10512059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FERMENTATION AND ISOLATION OF EVERNINOMICIN.
    WAGMAN GH; LUEDEMANN GM; WEINSTEIN MJ
    Antimicrob Agents Chemother (Bethesda); 1964; 10():33-7. PubMed ID: 14287954
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative thin-layer chromatography of everninomicin D.
    Kabasakalian P; Kalliney S
    J Chromatogr; 1973 Nov; 86(1):145-9. PubMed ID: 4765304
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibiotics--TAZ/PIPC, synercid, linezolid, everninomicin].
    Hidai H
    Nihon Rinsho; 2001 Apr; 59(4):785-9. PubMed ID: 11305007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antimicrobial activities of a novel everninomicin for multiple drug-resistant Streptococcus pneumoniae isolates in Japan.
    Miyazaki S; Tateda K; Matsumoto T; Ohno A; Ishii Y; Furuya N; Yamaguchi K
    J Antimicrob Chemother; 2001 Jun; 47(6):900-1. PubMed ID: 11389130
    [No Abstract]   [Full Text] [Related]  

  • 29. EVERNINOMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA CARBONACEA.
    WEINSTEIN MJ; LUEDEMANN GM; ODEN EM; WAGMAN GH
    Antimicrob Agents Chemother (Bethesda); 1964; 10():24-32. PubMed ID: 14287938
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemical modification of everninomicins.
    Ganguly AK; Girijavallabhan VM; Miller GH; Sarre OZ
    J Antibiot (Tokyo); 1982 May; 35(5):561-70. PubMed ID: 7107521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PHARMACOLOGICAL PROPERTIES OF EVERNINOMICIN D.
    BLACK J; CALESNICK B; FALCO FG; WEINSTEIN MJ
    Antimicrob Agents Chemother (Bethesda); 1964; 10():38-46. PubMed ID: 14287963
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of SCH27899 (Ziracin), an oligosaccharide everninomicin antibiotic, on urate kinetics in humans.
    Nagashima S; Niwa M; Nishiki K; Hosoya T; Hishida A; Uematsu T
    Eur J Clin Pharmacol; 2004 Jun; 60(4):255-64. PubMed ID: 15088132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical modifications and structure activity studies of ziracin and related everninomicin antibiotics.
    Ganguly AK; McCormick JL; Saksena AK; Das PR; Chan TM
    Bioorg Med Chem Lett; 1999 Apr; 9(8):1209-14. PubMed ID: 10328315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents.
    Cormican MG; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1995 Dec; 23(4):157-60. PubMed ID: 9407222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity.
    Davis JW; Goodsaid FM; Bral CM; Obert LA; Mandakas G; Garner CE; Collins ND; Smith RJ; Rosenblum IY
    Toxicol Appl Pharmacol; 2004 Oct; 200(1):16-26. PubMed ID: 15451304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group.
    Marshall SA; Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):19-25. PubMed ID: 9990471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative cyclizations in orthosomycin biosynthesis expand the known chemistry of an oxygenase superfamily.
    McCulloch KM; McCranie EK; Smith JA; Sarwar M; Mathieu JL; Gitschlag BL; Du Y; Bachmann BO; Iverson TM
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11547-52. PubMed ID: 26240321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Directed studies towards the total synthesis of (+)-13-deoxytedanolide: simple and convenient synthesis of the C8-C16 fragment.
    Meiries S; Bartoli A; Decostanzi M; Parrain JL; Commeiras L
    Org Biomol Chem; 2013 Aug; 11(29):4882-90. PubMed ID: 23765336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymmetric Synthesis of Calyculin C. 1. Synthesis of the C(1)-C(25) Fragment.
    Scarlato GR; DeMattei JA; Chong LS; Ogawa AK; Lin MR; Armstrong RW
    J Org Chem; 1996 Sep; 61(18):6139-6152. PubMed ID: 11667448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Spongistatins: Architecturally Complex Natural Products-Part One: A Formal Synthesis of (+)-Spongistatin 1 by Construction of an Advanced ABCD Fragment.
    Smith Iii AB; Doughty VA; Lin Q; Zhuang L; McBriar MD; Boldi AM; Moser WH; Murase N; Nakayama K; Sobukawa M
    Angew Chem Int Ed Engl; 2001 Jan; 40(1):191-195. PubMed ID: 29711948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.